Cargando…

Cancer Treatment–Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer

Cancer and cancer therapies can have a negative impact on bone health. Because cancer is a common diagnosis, survivorship concerns for osteoporosis and fragility fractures are an important component of care. This review addresses management of bone health in nonmetastatic cancer survivorship with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taxel, Pamela, Faircloth, Erika, Idrees, Sana, Van Poznak, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007245/ https://www.ncbi.nlm.nih.gov/pubmed/29942922 http://dx.doi.org/10.1210/js.2018-00052

Ejemplares similares

Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
por: Van Poznak, Catherine
Publicado: (2010)

Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase
por: Quiroz-Munoz, Mariana, et al.
Publicado: (2019)

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology
por: Droz, Jean-Pierre, et al.
Publicado: (2010)

Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision
por: Tjalma, W.A.A.
Publicado: (2015)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Bone loss induced by cancer treatments in breast and prostate cancer patients
por: Castañeda, Santos, et al.
Publicado: (2022)

Mosaic loss of the Y chromosome and men's health
por: Fukami, Maki, et al.
Publicado: (2022)

Oncotype Dx Results in Multiple Primary Breast Cancers
por: Toole, Michael J., et al.
Publicado: (2014)

Endocrine manipulations in cancer prostate: A review
por: Rajput, Rajesh, et al.
Publicado: (2012)

Emerging Role of Extracellular Vesicles in Prostate Cancer
por: Ludwig, Megan, et al.
Publicado: (2021)

Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients
por: Castañeda, Santos, et al.
Publicado: (2022)

Tenofovir-associated bone density loss
por: Grigsby, Iwen F, et al.
Publicado: (2010)

Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)

Sniffing out prostate cancer: a new clinical opportunity
por: Taverna, Gianluigi, et al.
Publicado: (2015)

Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis
por: Veeranki, Sudhakar
Publicado: (2013)

OTHR-12. DRIVING RECOMMENDATIONS IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER BRAIN METASTASES
por: Swartz, Leigh, et al.
Publicado: (2019)

Circulating Tumor Cells in Early Breast Cancer
por: Thery, Laura, et al.
Publicado: (2019)

Graphene-based biosensors for the detection of prostate cancer protein biomarkers: a review
por: Xu, Li, et al.
Publicado: (2019)

Active surveillance for low-risk prostate cancer – in pursuit of a standardized protocol
por: Sosnowski, Roman, et al.
Publicado: (2020)

Frailty and bone health in European men
por: Giannopoulou, Aggeliki
Publicado: (2017)

Genome-Wide Estrogen Receptor Activity in Breast Cancer
por: Farcas, Anca M, et al.
Publicado: (2020)

Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2022)

Diagnostic Challenges in Prostate Cancer and (68)Ga-PSMA PET Imaging: A Game Changer?
por: Zaman, Maseeh uz, et al.
Publicado: (2017)

Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach
por: Murugesan, Raja, et al.
Publicado: (2022)

Targeted drugs and Psycho-oncological intervention for breast cancer patients
por: D’Abramo, Flavio, et al.
Publicado: (2016)

Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer
por: Casey, Máire‐Caitlín, et al.
Publicado: (2016)

Tumor‐associated macrophages: An important player in breast cancer progression
por: Huang, Xinqun, et al.
Publicado: (2021)

A Case of Chronic Bone Pain in Mc-CuneAlbright Syndrome
por: Nallu, Ravali, et al.
Publicado: (2021)

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects
por: Abidi, Afroz
Publicado: (2013)

Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer
por: Egerton, Nancy
Publicado: (2010)

Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease
por: Eisner, Alvin, et al.
Publicado: (2011)

Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase
por: Trager, Megan H, et al.
Publicado: (2021)

MON-509 Crack in My Bone of Certain Significance: Clinical Vignette and Literature Review
por: Jalil, Fatima, et al.
Publicado: (2019)

Bone Health in Men with Prostate Cancer: Review Article
por: A M El Badri, Salma, et al.
Publicado: (2019)

Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer
por: Cheung, Yee-Ming, et al.
Publicado: (2019)

Serum Lipidomic Profiling in Breast Cancer to Identify Screening, Diagnostic, and Prognostic Biomarkers
por: Fichtali, Karima, et al.
Publicado: (2020)

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
por: Pandey, Kamal, et al.
Publicado: (2019)

Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment
por: Jazwinska, Dorota E., et al.
Publicado: (2023)

Functional roles of CTCF in breast cancer
por: Oh, Sumin, et al.
Publicado: (2017)

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations
por: Brown, J.E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4cskqvc1amuuik7sh4ce6516u9